362(top 1%)
papers
14.7K(top 1%)
citations
55(top 1%)
h-index
115(top 1%)
g-index
391
all documents
15.9K
doc citations
2.7K
citing journals

Top Articles

#TitleJournalYearCitations
1Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Autophagy20164,701
2Tumor Exosomes Inhibit Differentiation of Bone Marrow Dendritic CellsJournal of Immunology2007373
3Regulation of EMT in Colorectal Cancer: A Culprit in MetastasisCancers2017365
4Virologic and Immunologic Determinants of Heterosexual Transmission of Human Immunodeficiency Virus Type 1 in AfricaAIDS Research and Human Retroviruses2001338
5Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort studyLancet Haematology,the2017338
6Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and CJournal of Virology2008337
7Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretionLeukemia2018304
8Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failureBlood2016255
9Talimogene laherparepvec: First in class oncolytic virotherapyHuman Vaccines and Immunotherapeutics2018247
10Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemiaNature Communications2016218
11Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphomaBlood2018199
12Regions of the JAK2 Tyrosine Kinase Required for Coupling to the Growth Hormone ReceptorJournal of Biological Chemistry1995152
13Warfarin Dosing in Patients With Impaired Kidney FunctionAmerican Journal of Kidney Diseases2010147
14Palmitoylation-dependent activation of MC1R prevents melanomagenesisNature2017143
15Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working GroupLancet Oncology, The2021136
16TopBP1 recruits Brg1/Brm to repress E2F1-induced apoptosis, a novel pRb-independent and E2F1-specific control for cell survivalGenes and Development2004135
17Regulation of E2F1 by BRCT Domain-Containing Protein TopBP1Molecular and Cellular Biology2003131
18Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cellsScience Translational Medicine2016130
19First Clinical Study of the B-Cell Maturation Antigen (BCMA) 2+1 T Cell Engager (TCE) CC-93269 in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Interim Results of a Phase 1 Multicenter TrialBlood2019127
20Resource Use and Medicare Costs During Lay Navigation for Geriatric Patients With CancerJAMA Oncology2017126
21Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast CancerJAMA Oncology2020119
22Safety of Polysorbate 80 in the Oncology SettingAdvances in Therapy2018114
23Safety, Tolerance, and Efficacy of Posaconazole Therapy in Patients with Nonmeningeal Disseminated or Chronic Pulmonary CoccidioidomycosisClinical Infectious Diseases2007110
24Pretreatment with Dexamethasone Increases Antitumor Activity of Carboplatin and Gemcitabine in Mice Bearing Human Cancer XenograftsClinical Cancer Research2004105
25MIR106B and MIR93 Prevent Removal of Bacteria From Epithelial Cells by Disrupting ATG16L1-Mediated AutophagyGastroenterology201498
26Myristoylation confers noncanonical AMPK functions in autophagy selectivity and mitochondrial surveillanceNature Communications201598
27Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell diseaseBlood Advances202093
28A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphomaBlood202092
29Regulation of TopBP1 oligomerization by Akt/PKB for cell survivalEMBO Journal200687
30Parsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignanciesBlood201984
31Comparing and Validating Machine Learning Models for Mycobacterium tuberculosis Drug DiscoveryMolecular Pharmaceutics201883
32The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cellsBritish Journal of Cancer200380
33MCPH1/BRIT1 cooperates with E2F1 in the activation of checkpoint, DNA repair and apoptosisEMBO Reports200880
34Implementation and Impact of Patient Lay Navigator-Led Advance Care Planning ConversationsJournal of Pain and Symptom Management201779
35A Role for 14-3-3τ in E2F1 Stabilization and DNA Damage-induced ApoptosisJournal of Biological Chemistry200477
36γδ T cells: A new frontier for immunotherapy?Biology of Blood and Marrow Transplantation200575
37Phase 1 Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53Clinical Cancer Research202174
38Metformin impairs the growth of liver kinase B1-intact cervical cancer cellsGynecologic Oncology201272
39Resectability of Pancreatic Adenocarcinoma in Patients with Locally Advanced Disease Downstaged by Preoperative Therapy: A Challenge for MDCTAmerican Journal of Roentgenology201071
40Piperlongumine induces autophagy by targeting p38 signalingCell Death and Disease201371
41Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALLBlood202170
42Effect of Cigarette Smoking on Epithelial to Mesenchymal Transition (EMT) in Lung CancerJournal of Clinical Medicine201669
43STRAP Promotes Stemness of Human Colorectal Cancer via Epigenetic Regulation of the NOTCH PathwayCancer Research201769
44International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trialsLeukemia202169
45Using a Tropism-Modified Adenoviral Vector to Circumvent Inhibitory Factors in Ascites FluidHuman Gene Therapy200068
46SIRT1 Activation Disrupts Maintenance of Myelodysplastic Syndrome Stem and Progenitor Cells by Restoring TET2 FunctionCell Stem Cell201868
47A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanomaAnnals of Oncology201567
48ATM-Mediated Stabilization of hMutL DNA Mismatch Repair Proteins Augments p53 Activation during DNA DamageMolecular and Cellular Biology200466
49Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomised trialLancet Oncology, The201366
50Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple MyelomaBiology of Blood and Marrow Transplantation201566